Ernest Camp to Antibodies, Monoclonal
This is a "connection" page, showing publications Ernest Camp has written about Antibodies, Monoclonal.
Connection Strength
0.782
-
CCR 20th Anniversary Commentary: RAS as a Biomarker for EGFR--Targeted Therapy for Colorectal Cancer-From Concept to Practice. Clin Cancer Res. 2015 Aug 15; 21(16):3578-80.
Score: 0.401
-
Roles of nitric oxide synthase inhibition and vascular endothelial growth factor receptor-2 inhibition on vascular morphology and function in an in vivo model of pancreatic cancer. Clin Cancer Res. 2006 Apr 15; 12(8):2628-33.
Score: 0.210
-
Management of bevacizumab-associated bowel perforation: a case series and review of the literature. Ann Oncol. 2008 Mar; 19(3):577-82.
Score: 0.059
-
Targeting of insulin-like growth factor-I receptor with a monoclonal antibody inhibits growth of hepatic metastases from human colon carcinoma in mice. Ann Surg Oncol. 2007 Oct; 14(10):2838-46.
Score: 0.057
-
Tyrosine kinase receptor RON in human pancreatic cancer: expression, function, and validation as a target. Cancer. 2007 Mar 15; 109(6):1030-9.
Score: 0.056